Evaluation of the carbapenem inactivation method (CIM) for detecting carbapenemase activity in enterobacteria

Objectives The objective of this study was to evaluate the accuracy of the CIM test in the detection of carbapenemase activity in 124 strains of Enterobacteriaceae. Methods A panel of 124 previously characterized Enterobacteriaceae was tested: 77 strains producing the following carbapenemase families: KPC (n = 14), GES (n = 22), NDM (n = 19), VIM (n = 4), IMP (n = 4) and OXA-48 (n = 14) and 47 non-carbapenemase producers. For the CIM method, an active susceptibility meropenem disc was exposed to a bacterial suspension of a test strain; when a carbapenemase is produced, the antibiotic is inactivated allowing uninhibited growth of an indicator strain after overnight incubation. A clear inhibition zone (?20 mm) was considered indicative of no-carbapenemase activity. Results All KPC, NDM, VIM, IMP or OXA-48 producing strains were unequivocally detected with the CIM test. CIM false negative results were obtained with eleven Enterobacter cloacae producing GES-6. Two other E. cloacae not producing carbapenemase (one with SHV-12, one hyperproducing AmpC) were positive by the test. The sensitivity and specificity of the assay compared to those of molecular methods were 85.7% and 95.7%, respectively. Conclusions The CIM method proved to be inexpensive and easy to interpret. It provided less than optimal results in the detection of GES-6 activity

Epidemiology and spatio‐temporal analysis of West Nile virus in horses in Spain between 2010 and 2016

During the last decade, West Nile virus (WNV) outbreaks have increased sharply in both horses and human in Europe. The aims of this study were to evaluate characteristics and spatio‐temporal distribution of WNV outbreaks in horses in Spain between 2010 and 2016 in order to identify the environmental variables most associated with WNV occurrence and to generate high‐resolution WNV suitability maps to inform risk‐based surveillance strategies in this country. Between August 2010 and November 2016, a total of 403 WNV suspected cases were investigated, of which, 177 (43.9%) were laboratory confirmed. Mean values of morbidity, mortality and case fatality rates were 7.5%, 1.6% and 21.2%, respectively. The most common clinical symptoms were as follows: tiredness/apathy, recumbency, muscular tremor, ataxia, incoordination and hyperaesthesia. The outbreaks confirmed during the last 7 years, with detection of WNV RNA lineage 1 in 2010, 2012, 2013, 2015 and 2016, suggest an endemic circulation of the virus in Spain. The spatio‐temporal distribution of WNV outbreaks in Spain was not homogeneous, as most of them (92.7%) were concentrated in western part of Andalusia (southern Spain) and significant clusters were detected in this region in two non‐consecutive years. These findings were supported by the results of the space–time scan statistics permutation model. A presence‐only MaxEnt ecological niche model was used to generate a suitability map for WNV occurrence in Andalusia. The most important predictors selected by the Ecological Niche Modeling were as follows: mean annual temperature (49.5% contribution), presence of Culex pipiens (19.5% contribution), mean annual precipitation (16.1% contribution) and distance to Ramsar wetlands (14.9% contribution). Our results constitute an important step for understanding WNV emergence and spread in Spain and will provide valuable information for the development of more cost‐effective surveillance and control programmes and improve the protection of horse and human populations in WNV‐endemic areas.info:eu-repo/semantics/acceptedVersio

La leishmaniasis en España: evolución de los casos notificados a La Red Nacional de Vigilancia Epidemiológica desde 2005 a 2017 y resultados de la vigilancia de 2014 a 2017

[ES] La leishmaniasis es una enfermedad endémica en España. Es de declaración obligatoria en todo el territorio desde 2015 a través de la Red Nacional de Vigilancia Epidemiológica (RENAVE). Los objetivos son conocer su distribución temporal y espacial, describir la epidemiología de los casos autóctonos y conocer la calidad de las notificaciones. Se realizó un estudio descriptivo en el que se analizó la distribución temporal de casos y las tasas de las comunidades autónomas (CCAA) con notificación estable (2005 a 2017). Además, a partir de los casos autóctonos notificados entre 2014 y 2017 se realizó un estudio descriptivo que incluyó la distribución temporal y espacial (casos y tasas). La calidad se midió según la exhaustividad en la cumplimentación de las variables. Entre 2005 y 2017 hubo 8 CCAA con notificación estable (media 141 casos/año, tasa de período 0,62 casos/100.000 hab.). Hubo picos en 2011 y 2012 debidos principalmente a la Comunidad de Madrid. Excluyendo los casos de la C. de Madrid (TI Otras) la evolución observada fue más estable, con tendencia ascendente desde 2012. Entre 2014 y 2017 hubo 1359 casos autóctonos (media 340 casos/año; tasa 0,76) de 15 CCAA, con una tendencia ascendente. El mayor número correspondió a enero y junio. 5 CCAA acumularon el 89,9% de los casos del período: Comunidad Valenciana, Comunidad de Madrid, Cataluña, Baleares y Andalucía. Presentaron tasas superiores a la del período Baleares, Comunidad Valenciana, Comunidad de Madrid y Castilla La-Mancha. El 61,1% de los casos eran hombres y la edad mediana 48 años. Las tasas más elevadas se observan en los niños y niña

Thermal neutron background at Laboratorio Subterráneo de Canfranc (LSC)

The thermal neutron background at Laboratorio Subterráneo de Canfranc (LSC) has been determined using several He proportional counter detectors. Bare and Cd shielded counters were used in a series of long measurements. Pulse shape discrimination techniques were applied to discriminate between neutron and gamma signals as well as other intrinsic contributions. Montecarlo simulations allowed us to estimate the sensitivity of the detectors and calculate values for the background flux of thermal neutrons inside Hall-A of LSC. The obtained value is (3.5±0.8)×10 n/cms, and is within an order of magnitude compared to similar facilities.This work was supported partially by the Spanish Ministerio de Ciencia e Innovación and its Plan Nacional de I+D+i de Física de Partículas projects: FPA2016-76765-P and FPA2018-096717-B-C21. The authors want to acknowledge the help provided by the staff at LSC in the preparation and support for this work

Coastal risk mitigation by green infrastructure in Latin America

This paper aims to highlight the prevailing experiences of Latin America and to clarify what ‘green infrastructure’ entails in addition to describing seven case studies from a range of coastal ecosystems (wetlands, coastal dunes, beaches and coral reefs) at scales varying from local to regional. The case studies are categorised according to their degree of naturalness (nature-based, engineered ecosystems, soft engineering, ecologically enhanced hard infrastructure and de-engineering). Generally, the implementation of green infrastructure projects aims to increase resilience, enhance the provision of ecosystem services, recover biodiversity, reduce the negative effects of hard infrastructure and implement corrective measures. The greatest benefits of these projects relate to the creation of multi-functional spaces, which often combine the above advantages with improved opportunities for recreation and/or economic activities. It is hoped that this paper will disseminate the experience in green infrastructure among academics and practitioners and stimulate wider adoption of green infrastructure projects and good practices

Neutron capture measurements with high efficiency detectors and the Pulse Height Weighting Technique

Neutron capture cross section measurements in time-of-flight facilities are usually performed by detecting the prompt γ-rays emitted in the capture reactions. One of the difficulties to be addressed in these measurements is that the emitted γ-rays may change with the neutron energy, and therefore also the detection efficiency. To deal with this situation, many measurements use the so called Total Energy Detection (TED) technique, usually in combination with the Pulse Height Weighting Technique (PHWT). With it, it is sought that the detection efficiency depends only on the total energy of the γ-ray cascade, which does not vary much with the neutron energy. This technique was developed in the 1960s and has been used in many neutron capture experiments to date. One of the requirements of the technique is that γ-ray detectors have a low efficiency. This has meant that the PHWT has been used with experimental setups with low detection efficiencies. However, this condition does not have to be fulfilled by the experimental system as a whole. The main goal of this work is to show that it is possible to measure with a high efficiency detection system that uses the PHWT, and how to analyze the measured data.This work was supported in part by the I+D+i grant PGC2018- 096717-B-C21 funded by MCIN/AEI/10.13039/501100011033 and by the European Commission H2020 Framework Programme project SANDA (Grant agreement ID: 847552)

Measuring Vitamin D3 Metabolic Status, Comparison between Vitamin D Deficient and Sufficient Individuals

The main branch of vitamin D3 metabolism involves several hydroxylation reactions to obtain mono-, di- and trihydroxylated metabolites, including the circulating and active forms—25(OH)D3 and 1,25(OH)2D3, respectively. However, most clinical trials strictly target the determination of 25(OH)D3 to offer a view of the metabolic status of vitamin D3. Due to the growing interest in expanding this restricted view, we have developed a method for measuring vitamin D3 metabolism by determination of vitamin D3, 25(OH)D3, 24,25(OH)2D3, 1,25(OH)2D3 and 1,24,25(OH)3D3 in human plasma. The method was based on SPE–LC–MS/MS with a large volume injection of human plasma (240 µL). Detection of di- and trihydroxymetabolites, found at the picogram per milliliter level, was attained by the combined action of high preconcentration and clean-up effects. The method allows obtaining information about ratios such as the known vitamin D metabolite ratio (24,25(OH)2D3/25(OH)D3), which can provide complementary views of vitamin D3 metabolic status. The method was applied to a cohort of obese patients and a reference cohort of healthy volunteers to find metabolic correlations between target analytes as well as differences as a function of vitamin D levels within and between cohorts

The QUIJOTE experiment: project overview and first results

QUIJOTE (Q-U-I JOint TEnerife) is a new polarimeter aimed to characterize the polarization of the Cosmic Microwave Background and other Galactic and extragalactic signals at medium and large angular scales in the frequency range 10-40 GHz. The multi-frequency (10-20~GHz) instrument, mounted on the first QUIJOTE telescope, saw first light on November 2012 from the Teide Observatory (2400~m a.s.l). During 2014 the second telescope has been installed at this observatory. A second instrument at 30~GHz will be ready for commissioning at this telescope during summer 2015, and a third additional instrument at 40~GHz is now being developed. These instruments will have nominal sensitivities to detect the B-mode polarization due to the primordial gravitational-wave component if the tensor-to-scalar ratio is larger than r=0.05.Comment: To appear in "Highlights of Spanish Astrophysics VIII", Proceedings of the XI Scientific Meeting of the Spanish Astronomical Society, Teruel, Spain (2014

Impact of the COVID-19 Pandemic on a Cancer Fast-Track Programme

Introduction: The COVID-19 pandemic has disrupted many aspects of clinical practice in oncology, particularly regarding early cancer diagnosis, sparking public health concerns that possible delays could increase the proportion of patients diagnosed at advanced stages. In 2009, a cancer fast-track program (CFP) was implemented at the Clinico-Malvarrosa Health Department in Valencia, Spain with the aim of shortening waiting times between suspected cancer symptoms, diagnosis and therapy initiation. Objectives: The study aimed to explore the effects of the COVID-19 pandemic on our cancer diagnosis fast-track program. Methods: The program workflow (patients included and time periods) was analysed from the beginning of the state of alarm on March 16th, 2020 until March 15th, 2021. Data was compared with data from the same period of time from the year before (2019). Results: During the pandemic year, 975 suspected cancer cases were submitted to the CFP. The number of submissions only decreased during times of highest COVID-19 incidence and stricter lockdown, and overall, referrals were slightly higher than in the previous 2 years. Cancer diagnosis was confirmed in 197 (24.1%) cases, among which 33% were urological, 23% breast, 16% gastrointestinal and 9% lung cancer. The median time from referral to specialist appointment was 13 days and diagnosis was reached at a median of 18 days. In confirmed cancer cases, treatment was started at around 30 days from time of diagnosis. In total, 61% of cancer disease was detected at early stage, 20% at locally advanced stage, and 19% at advanced stage, displaying time frames and case proportions similar to pre-pandemic years. Conclusions: Our program has been able to maintain normal flow and efficacy despite the challenges of the current pandemic, and has proven a reliable tool to help primary care physicians referring suspected cancer patients.S

Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA)

Introduction Mild cognitive impairment (MCI) is a term used to describe a level of decline in cognition which is seen as an intermediate stage between normal ageing and dementia, and which many consider to be a prodromal stage of neurodegeneration that may become dementia. That is, it is perceived as a high risk level of cognitive change. The increasing burden of dementia in our society, but also our increasing understanding of its risk factors and potential interventions, require diligent management of MCI in order to find strategies that produce effective prevention of dementia. Aim To update knowledge regarding mild cognitive impairment, and to bring together and appraise evidence about the main features of clinical interest: definitions, prevalence and stability, risk factors, screening, and management and intervention. Methods Literature review and consensus of expert opinion. Results and conclusion MCI describes a level of impairment in which deteriorating cognitive functions still allow for reasonable independent living, including some compensatory strategies. While there is evidence for some early risk factors, there is still a need to more precisely delineate and distinguish early manifestations of frank dementia from cognitive impairment that is less likely to progress to dementia, and furthermore to develop improved prospective evidence for positive response to intervention. An important limitation derives from the scarcity of studies that take MCI as an endpoint. Strategies for effective management suffer from the same limitation, since most studies have focused on dementia. Behavioural changes may represent the most cost-effective approach